Evidence map›Paper›PMID 41778422›Full record

ArticleACS applied materials & interfaces2026

Development of Au

Li-Xing Yang, Yi-Chun Chiu, Yi-Lun Chen, Ting-Ying Chen, Yi-Tseng Tsai, Yu-Cheng Chin, Ya-Ling Yeh, Ying-Jan Wang, Chih-Chia Huang, Rong-Jane Chen and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in ACS applied materials & interfaces, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Li-Xing YangDepartment of Photonics, National Cheng Kung University, Tainan 701, Taiwan.
Yi-Chun ChiuDivision of Urology, Department of Surgery, Yangming Branch, Taipei City Hospital, Taipei 111, Taiwan.
Yi-Lun ChenDepartment of Applied Chemistry, National Pingtung University, Pingtung 900, Taiwan.
Ting-Ying ChenDepartment of Applied Chemistry, National Pingtung University, Pingtung 900, Taiwan.
Yi-Tseng TsaiDepartment of Photonics, National Cheng Kung University, Tainan 701, Taiwan.
Yu-Cheng ChinDepartment of Photonics, National Cheng Kung University, Tainan 701, Taiwan.ORCID 0000-0002-0302-7925
Ya-Ling YehDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Ying-Jan WangDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.ORCID 0000-0003-3169-2495
Chih-Chia HuangDepartment of Photonics, National Cheng Kung University, Tainan 701, Taiwan.ORCID 0000-0002-9486-8665
Rong-Jane ChenDepartment of Environmental and Occupational Health, College of Medicine, National Cheng Kung University, Tainan 704, Taiwan.
Mei-Yi LiaoDepartment of Applied Chemistry, National Pingtung University, Pingtung 900, Taiwan.ORCID 0000-0003-3872-0049

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The development of multimetallic nanoparticles for cancer treatment represents a significant advancement in the field of nanomedicine. We introduce a Cu-templated synthesis method to create Au

Indexed as

Antineoplastic AgentsAutophagyMetal NanoparticlesNanocompositesAnimalsCell Line, TumorCopperFerroptosisGoldHumansMicePalladiumTumor MicroenvironmentAntineoplastic AgentsCopperGoldPalladiumalloy nanoparticlesautophagy modulationcancer-selective therapyferroptosisimmunoregulationmetal-based nanomedicinemultimetallic nanocomposites

Identifiers

PMID41778422
PMCPMC13006959

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.